369 related articles for article (PubMed ID: 31433414)
1. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
[TBL] [Abstract][Full Text] [Related]
3. Systematically Characterize the Anti-Alzheimer's Disease Mechanism of Lignans from
Wei M; Liu Y; Pi Z; Li S; Hu M; He Y; Yue K; Liu T; Liu Z; Song F; Liu Z
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934777
[TBL] [Abstract][Full Text] [Related]
4. An integrated strategy using LC-MS/MS combined with
Fu J; Zhang H; Liu S; Wu J; Zhang Y; Gao Y; Song F; Qin Y; Hu X; Liu Z
Food Funct; 2021 Oct; 12(19):8932-8945. PubMed ID: 34606559
[No Abstract] [Full Text] [Related]
5. Metabolic mapping of Schisandra chinensis lignans and their metabolites in rats using a metabolomic approach based on HPLC with quadrupole time-of-flight MS/MS spectrometry.
Wang J; Jiang B; Shan Y; Wang X; Lv X; Mohamed J; Li H; Wang C; Chen J; Sun J
J Sep Sci; 2020 Jan; 43(2):378-388. PubMed ID: 31625256
[TBL] [Abstract][Full Text] [Related]
6. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and metabolomics approach based on UHPLC-MS to evaluate therapeutic effect of lignans from S. Chinensis in alzheimer's disease.
Zhou Y; Wei M; Fan M; Liu Z; Wang A; Liu Y; Men L; Pi Z; Liu Z; Song F
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122859. PubMed ID: 34274605
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS.
Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
J Pharm Biomed Anal; 2020 Jan; 177():112874. PubMed ID: 31542420
[TBL] [Abstract][Full Text] [Related]
9. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity.
Wei B; Li Q; Fan R; Su D; Ou X; Chen K; Chen X; Jia Y; Bi K
J Mass Spectrom; 2013 Apr; 48(4):448-58. PubMed ID: 23584938
[TBL] [Abstract][Full Text] [Related]
10. An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
Zhang Y; Lv X; Liu R; Zhang M; Liu H; Gao H; Zhang Q; Xu H; Li Q; Bi K
J Chromatogr A; 2019 Aug; 1598():122-131. PubMed ID: 31047662
[TBL] [Abstract][Full Text] [Related]
11. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
[TBL] [Abstract][Full Text] [Related]
12. An integrated study on the comprehensive mechanism of
Fu J; Li J; Sun Y; Liu S; Song F; Liu Z
Food Funct; 2023 Jan; 14(2):734-745. PubMed ID: 36562313
[TBL] [Abstract][Full Text] [Related]
13. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Wei B; Li Q; Su D; Fan R; Zhao L; Geng L; He B; Chen X; Jia Y; Bi K
J Pharm Biomed Anal; 2013 Apr; 77():120-7. PubMed ID: 23416367
[TBL] [Abstract][Full Text] [Related]
14. Gender-dependent pharmacokinetics of lignans in rats after single and multiple oral administration of Schisandra chinensis extract.
Xu H; Gan J; Liu X; Wu R; Jin Y; Li M; Yuan B
J Ethnopharmacol; 2013 May; 147(1):224-31. PubMed ID: 23501155
[TBL] [Abstract][Full Text] [Related]
15. Serum and urine metabolomics based on UPLC-QTOF/MS reveal the effect and potential mechanism of "schisandra-evodia" herb pair in the treatment of Alzheimer's disease.
Pang C; Wang R; Liu K; Yuan X; Ni J; Cao Q; Chen Y; Dong PL; Han H
Biomed Chromatogr; 2024 Jul; 38(7):e5882. PubMed ID: 38649307
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.
Wei BB; Liu MY; Chen ZX; Wei MJ
Acta Pharmacol Sin; 2018 Apr; 39(4):616-625. PubMed ID: 29323336
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-based urinary metabolomics for exploring the treatment effects of Radix ginseng-Schisandra chinensis herb pair on Alzheimer's disease in rats.
Wang A; Pi Z; Liu S; Zheng Z; Liu Z; Song F
J Sep Sci; 2021 Aug; 44(16):3158-3166. PubMed ID: 34110709
[TBL] [Abstract][Full Text] [Related]
19. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
20. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer's disease by UPLC-QTOF/MS-based plasma metabolomics study.
Sun LM; Zhu BJ; Cao HT; Zhang XY; Zhang QC; Xin GZ; Pan LM; Liu LF; Zhu HX
J Pharm Biomed Anal; 2018 Mar; 151():75-83. PubMed ID: 29310050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
